首页> 美国卫生研究院文献>Stroke Research and Treatment >Clinical Trials in Cardiac Arrest and Subarachnoid Hemorrhage: Lessons from the Past and Ideas for the Future
【2h】

Clinical Trials in Cardiac Arrest and Subarachnoid Hemorrhage: Lessons from the Past and Ideas for the Future

机译:心脏骤停和蛛网膜下腔出血的临床试验:过去的经验教训和未来的想法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction. Elevated intracranial pressure that occurs at the time of cerebral aneurysm rupture can lead to inadequate cerebral blood flow, which may mimic the brain injury cascade that occurs after cardiac arrest. Insights from clinical trials in cardiac arrest may provide direction for future early brain injury research after subarachnoid hemorrhage (SAH). Methods. A search of PubMed from 1980 to 2012 and clinicaltrials.gov was conducted to identify published and ongoing randomized clinical trials in aneurysmal SAH and cardiac arrest patients. Only English, adult, human studies with primary or secondary mortality or neurological outcomes were included. Results. A total of 142 trials (82 SAH, 60 cardiac arrest) met the review criteria (103 published, 39 ongoing). The majority of both published and ongoing SAH trials focus on delayed secondary insults after SAH (70%), while 100% of cardiac arrest trials tested interventions within the first few hours of ictus. No SAH trials addressing treatment of early brain injury were identified. Twenty-nine percent of SAH and 13% of cardiac arrest trials showed outcome benefit, though there is no overlap mechanistically. Conclusions. Clinical trials in SAH assessing acute brain injury are warranted and successful interventions identified by the cardiac arrest literature may be reasonable targets of the study.
机译:介绍。脑动脉瘤破裂时发生的颅内压升高可导致脑血流量不足,这可模仿心脏骤停后发生的脑损伤级联反应。来自心脏骤停的临床试验的见解可能为蛛网膜下腔出血(SAH)后未来早期脑损伤研究提供方向。方法。检索1980年至2012年的PubMed和Clinicaltrials.gov,以鉴定已发表和正在进行的针对动脉瘤SAH和心脏骤停患者的随机临床试验。仅包括具有主要或次要死亡率或神经系统结果的英语,成人,人体研究。结果。共有142项试验(82项SAH,60例心脏骤停)符合了审查标准(已出版103项,正在进行39项)。在已发表和正在进行的SAH试验中,大多数都侧重于SAH后的继发性继发感染(70%),而100%的心脏骤停试验则在发作的最初几个小时内对干预措施进行了测试。尚未找到针对早期脑损伤治疗的SAH试验。尽管在机制上没有重叠,但29%的SAH和13%的心脏骤停试验显示出预后获益。结论。必须进行SAH评估急性脑损伤的临床试验,并且由心脏骤停文献确定的成功干预措施可能是该研究的合理目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号